Channel Avatar

GANZ.P @UCqQ-s-5tCof7A6QAUKjZaRg@youtube.com

461 subscribers - no pronouns :c

More from this channel (soon)


12:34
Pharmacovigilance System Master File
23:20
Signal Management
01:33:26
[ASMR]λœ¬κΈˆμ—†λŠ” κ³ μ†λ„λ‘œ μš΄μ „|Highway Driving|μ„œμšΈ β†’ νŒ”λ‹Ή
25:21
(2)Periodic/Development Safety Update Report
27:11
(1)Periodic/Development Safety Update Report
18:23
(2)Pharmacovigilance Planning
25:11
(1)Pharmacovigilance Planning
02:19:20
[ASMR]λœ¬κΈˆμ—†λŠ” κ³ μ†λ„λ‘œ μš΄μ „|Highway Driving|μ„œμšΈ β†’ 영주
27:41
(3)Reviewerλ₯Ό μœ„ν•œ ICH E2B(R3) Guideline의 이해
25:17
(2)Reviewerλ₯Ό μœ„ν•œ ICH E2B(R3) Guideline의 이해
30:40
(1)Reviewerλ₯Ό μœ„ν•œ ICH E2B(R3) Guideline의 이해
17:51
μ‹œνŒ ν›„ μ΄μƒμ‚¬λ‘€μ˜ 관리
14:25
(2)μ΄μƒμ‚¬λ‘€μ˜ μˆ˜μ§‘, 평가 및 보고
24:07
(1)μ΄μƒμ‚¬λ‘€μ˜ μˆ˜μ§‘, 평가 및 보고
36:56
Global Guideline & Glossary
15:24
(2023)μž„μƒμ‹œν—˜ κΈ°λ³Έλ¬Έμ„œμ˜ 관리(3)
36:12
(2023)μž„μƒμ‹œν—˜ κΈ°λ³Έλ¬Έμ„œμ˜ 관리(2)
25:15
점검 및 μ‹€νƒœμ‘°μ‚¬μ˜ μ‹€μ‹œμ™€ ν›„μ†μ‘°μΉ˜
25:59
μž„μƒμ‹œν—˜ κΈ°λ³Έλ¬Έμ„œμ˜ 관리(1)
25:01
μž„μƒμ‹œν—˜ ν’ˆμ§ˆλ³΄μ¦μ˜ κΈ°λ³Έ κ°œλ…
11:54
μž„μƒμ‹œν—˜κ²€μ²΄λΆ„μ„κΈ°κ΄€μ˜ 지정 및 운영
26:14
μž„μƒμ‹œν—˜ κ΄€λ ¨ μ€€μˆ˜μ‚¬ν•­
19:03
μž„μƒμ‹œν—˜μ‹€μ‹œκΈ°κ΄€μ˜ 지정 및 운영
22:04
생물학적동등성 μ‹œν—˜μ˜ μ‹€μ‹œ(1)
18:36
μ˜μ•½ν’ˆλ™λ“±μ„± μ‹œν—˜μ˜ κ°œμš”
18:30
생물학적동등성 μ‹œν—˜μ˜ μ‹€μ‹œ(2)
28:33
μƒμ²΄λ§‰μ˜ ꡬ쑰와 물질의 이동
37:34
μ•½λ¬Όλ™νƒœν•™μ˜ κΈ°λ³Έκ°œλ…
23:50
약물동λ ₯ν•™μ˜ κΈ°λ³Έκ°œλ…
20:46
μž„μƒμ‹œν—˜μš© μ˜μ•½ν’ˆμ˜ κ°œλ…κ³Ό κ·œμ •
29:39
μž„μƒμ‹œν—˜μš© μ˜μ•½ν’ˆμ˜ μ œμ‘°μ™€ ν’ˆμ§ˆκ΄€λ¦¬
13:39
μž„μƒμ‹œν—˜μš© μ˜μ•½ν’ˆμ˜ 치료λͺ©μ λ“± μ‚¬μš©
12:19
μž„μƒμ‹œν—˜ μ΄μƒλ°˜μ‘μ˜ κΈ°λ³Έκ°œλ…
22:23
μž„μƒμ‹œν—˜ μ΄μƒλ°˜μ‘μ˜ 보고
29:03
μž„μƒμ‹œν—˜ μ΄μƒλ°˜μ‘μ˜ 평가
17:00
μž„μƒμ‹œν—˜ μ—°κ΅¬μœ€λ¦¬μ˜ λ°œμ „
19:14
μ˜μ•½ν’ˆ μž„μƒμ‹œν—˜κ΄€λ¦¬κΈ°μ€€(KGCP)
32:01
μž„μƒμ‹œν—˜κ³„νš 승인 절차
07:10
μ—°κ΅¬μž μž„μƒμ‹œν—˜
19:42
μž„μƒμ‹œν—˜κ³„νš μŠΉμΈμ œλ„ κ°œμš”
15:38
μž„μƒμ‹œν—˜ ν‰κ°€λ³€μˆ˜(Endpoint)
37:12
μž„μƒμ‹œν—˜κ³Ό 톡계적 μΆ”μ •
22:56
μž„μƒμ‹œν—˜ ν†΅κ³„λΆ„μ„μ˜ 절차
28:43
μž„μƒμ‹œν—˜κ³Ό λˆˆκ°€λ¦Ό(Blinding)
26:20
λ¬΄μž‘μœ„λ°°μ •(Randomization)
26:05
μ—λŸ¬μ™€ 편ν–₯(Error and Bias)
24:01
μž„μƒμ‹œν—˜μ˜ μ£Όμš” 섀계
24:31
λŒ€μ‘°κ΅°μ˜ μ„€μ •
31:56
μž„μƒμ‹œν—˜ κ³„νšμ„œμ˜ μž‘μ„±
26:09
μž„μƒμ‹œν—˜μ˜ μ£Όμš” μš©μ–΄(2)
32:36
μž„μƒμ‹œν—˜μ˜ κΈ°λ³Έ κ°œλ…κ³Ό 단계
27:56
μž„μƒμ‹œν—˜μ˜ μ£Όμš” μš©μ–΄(1)
22:49
μ˜μ•½ν’ˆ 개발 κ°œμš”
28:55
약사법 κ°œμš”
23:12
μš°λ¦¬λ‚˜λΌμ˜ 법령 체계
01:09:49
[2007] μ†Œλ¦Ώλ°”λžŒ 15μ£Όλ…„ 기념곡연(톡합)
01:31:43
[2002] μ†Œλ¦Ώλ°”λžŒ 10μ£Όλ…„ 기념곡연
00:43
[νƒ€μž„λž©μŠ€] 괌, 투λͺ¬λ² μ΄μ˜ 석양
01:00
[νƒ€μž„λž©μŠ€] 체코 ν”„λΌν•˜μ˜ 일λͺ°
02:27
이루마(Yiruma) Live - The River flows in you(Vocal)